Pro-Dex, Inc. (PDEX) Stock Score, Valuation & Financial Research
Pro-Dex, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 60/100.
Quick answer for PDEX
Pro-Dex, Inc. currently has a Wall Street Score of 60/100. The stored market price is $59.73. Its financial score is 51/100. Its valuation score is 69/100. These figures are a research snapshot, not a buy or sell recommendation.
What Pro-Dex, Inc. does
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
PDEX financial snapshot
- Wall Street Score:
- 60/100
- Current price:
- $59.73
- Market capitalization:
- $190.7M
- Revenue:
- $74.6M
- Net income:
- $12.0M
- Free cash flow:
- $-2.9M
- Cash:
- $10.0M
- Total debt:
- $20.2M
- EPS:
- 2.73
- P/E ratio:
- 21.9x
- Financial score:
- 51/100
- Valuation score:
- 69/100
- Revenue score:
- 46/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-2.9M, showing cash burn in the current stored period.
- The balance sheet shows $10.0M of cash versus $20.2M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 69/100, which Wall Street Score classifies as mixed within the model's valuation framework.
The financial score is 51/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research PDEX
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.